Clues to a modern mystery could be lurking in information collected generations ago. Clues to a modern mystery could be lurking in information collected generations ago.
Mayo Clinic Proceedings showing that Cologuard (mt-sDNA) is the most cost-effective colorectal cancer (CRC) screening option in the Alaska Native population, as compared to colonoscopy and the fecal immunochemical test (FIT), for a wide range of adherence scenarios. According to the model, Cologuard produced the highest number of quality adjusted life years (QALYs) gained and the largest reduction in CRC incidence.
1
Colorectal cancer is the second leading cause of cancer death for men and women in the United States,
2 in part because many cancers go undetected until later stages when treatment is less effective.
3 Alaska Native (AN) people have among the nation s highest reported incidence rates for CRC, at 89.0 per 100,000 people compared to 45.7 per 100,000 people for the entire United States.